Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Healthcare Realty Trust Analyst Ratings and Price Targets | NYSE:HR | Benzinga
Healthcare Realty Trust Inc has a consensus price target of $20.75 based on the ratings of 16 analysts. The high is $32 issued by Berenberg on May 10, 2022. The low is $15 issued by Stifel on February 20, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, Scotiabank, and Wedbush on March 10, 2025, February 25, 2025, and January 2, 2025, respectively. With an average price target of $16.33 between Wells Fargo, Scotiabank, and Wedbush, there's an implied -3.24% downside for Healthcare Realty Trust Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
Scotiabank
Wedbush
JP Morgan
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Healthcare Realty Trust
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/10/2025 | Buy Now | -5.21% | Wells Fargo | John Kilichowski45% | $17 → $16 | Maintains | Underweight | Get Alert |
| 02/25/2025 | Buy Now | 0.71% | Scotiabank | Nicholas Yulico56% | $18 → $17 | Maintains | Sector Perform | Get Alert |
| 01/02/2025 | Buy Now | -5.21% | Wedbush | Richard Anderson64% | $18 → $16 | Downgrade | Neutral → Underperform | Get Alert |
| 12/20/2024 | Buy Now | 12.56% | JP Morgan | Michael Mueller55% | → $19 | Downgrade | Overweight → Neutral | Get Alert |
| 10/01/2024 | Buy Now | 0.71% | Wells Fargo | James Feldman61% | $16 → $17 | Assumes | Underweight → Underweight | Get Alert |
| 08/07/2024 | Buy Now | 6.64% | Scotiabank | Nicholas Yulico56% | $17 → $18 | Maintains | Sector Perform | Get Alert |
| 08/05/2024 | Buy Now | 6.64% | Wedbush | Richard Anderson64% | $15 → $18 | Maintains | Neutral | Get Alert |
| 07/30/2024 | Buy Now | -5.21% | Wells Fargo | James Feldman61% | $17 → $16 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 07/09/2024 | Buy Now | 0.71% | Scotiabank | Nicholas Yulico56% | $16 → $17 | Maintains | Sector Perform | Get Alert |
| 06/14/2024 | Buy Now | 0.71% | Wells Fargo | James Feldman61% | $16 → $17 | Maintains | Equal-Weight | Get Alert |
| 05/30/2024 | Buy Now | -5.21% | Wells Fargo | James Feldman61% | $15 → $16 | Maintains | Equal-Weight | Get Alert |
| 05/16/2024 | Buy Now | -5.21% | Scotiabank | Nicholas Yulico56% | $15 → $16 | Maintains | Sector Perform | Get Alert |
| 05/08/2024 | Buy Now | -5.21% | Wedbush | Richard Anderson64% | $15 → $16 | Maintains | Neutral | Get Alert |
| 04/10/2024 | Buy Now | -11.14% | Wells Fargo | James Feldman61% | $18 → $15 | Maintains | Equal-Weight | Get Alert |
| 03/06/2024 | Buy Now | 0.71% | JP Morgan | Michael Mueller55% | $19 → $17 | Maintains | Overweight | Get Alert |
| 02/20/2024 | Buy Now | -11.14% | Wedbush | Richard Anderson64% | $19 → $15 | Downgrade | Outperform → Neutral | Get Alert |
| 02/20/2024 | Buy Now | -11.14% | Stifel | Stephen Manaker44% | $19 → $15 | Downgrade | Buy → Hold | Get Alert |
| 01/30/2024 | Buy Now | 6.64% | Deutsche Bank | Omotayo Okusanya63% | → $18 | Initiates | → Hold | Get Alert |
| 11/13/2023 | Buy Now | -5.21% | Wells Fargo | James Feldman61% | $17 → $16 | Maintains | Equal-Weight | Get Alert |
| 11/06/2023 | Buy Now | 0.71% | Wedbush | Richard Anderson64% | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 10/24/2023 | Buy Now | 0.71% | BTIG | Michael Gorman56% | → $17 | Upgrade | Neutral → Buy | Get Alert |
| 10/12/2023 | Buy Now | 12.56% | JP Morgan | Michael Mueller55% | → $19 | Upgrade | Neutral → Overweight | Get Alert |
| 10/10/2023 | Buy Now | 0.71% | Scotiabank | Nicholas Yulico56% | $19 → $17 | Maintains | Sector Perform | Get Alert |
| 10/06/2023 | Buy Now | 0.71% | BMO Capital | Juan Sanabria58% | $20 → $17 | Maintains | Market Perform | Get Alert |
| 10/03/2023 | Buy Now | 0.71% | Wedbush | Richard Anderson64% | → $17 | Initiates | → Outperform | Get Alert |
| 08/22/2023 | Buy Now | 0.71% | Citigroup | Michael Griffin67% | $19 → $17 | Maintains | Neutral | Get Alert |
| 08/11/2023 | Buy Now | 42.18% | Barclays | Steve Valiquette53% | $25 → $24 | Maintains | Equal-Weight | Get Alert |
| 05/11/2023 | Buy Now | 48.1% | Barclays | Steve Valiquette53% | $24 → $25 | Maintains | Overweight | Get Alert |
| 04/19/2023 | Buy Now | — | Wells Fargo | James Feldman61% | — | Initiates | → Equal-Weight | Get Alert |
| 03/29/2023 | Buy Now | 42.18% | Barclays | Steve Valiquette53% | $28 → $24 | Maintains | Overweight | Get Alert |
| 03/06/2023 | Buy Now | 18.48% | Credit Suisse | Omotayo Okusanya63% | $23 → $20 | Downgrade | Outperform → Neutral | Get Alert |
| 12/14/2022 | Buy Now | 18.48% | Citigroup | Michael Griffin67% | $22.5 → $20 | Downgrade | Buy → Neutral | Get Alert |
| 12/02/2022 | Buy Now | 30.33% | JP Morgan | Michael Mueller55% | $28 → $22 | Maintains | Neutral | Get Alert |
| 09/19/2022 | Buy Now | 65.88% | Citigroup | Michael Bilerman59% | $27 → $28 | Upgrade | Neutral → Buy | Get Alert |
| 08/11/2022 | Buy Now | 77.73% | SMBC Nikko | Richard Anderson64% | → $30 | Upgrade | Neutral → Outperform | Get Alert |
| 07/18/2022 | Buy Now | 71.8% | Credit Suisse | Sam Choe15% | $34 → $29 | Maintains | Outperform | Get Alert |
| 05/10/2022 | Buy Now | 89.57% | Berenberg | Conor Siversky43% | $35 → $32 | Downgrade | Buy → Hold | Get Alert |
| 04/26/2022 | Buy Now | 95.5% | Barclays | Steve Valiquette53% | → $33 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Healthcare Realty Trust (HR) stock?
The latest price target for Healthcare Realty Trust (NYSE:HR) was reported by Wells Fargo on March 10, 2025. The analyst firm set a price target for $16.00 expecting HR to fall to within 12 months (a possible -5.21% downside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Healthcare Realty Trust (HR)?
The latest analyst rating for Healthcare Realty Trust (NYSE:HR) was provided by Wells Fargo, and Healthcare Realty Trust maintained their underweight rating.
When was the last upgrade for Healthcare Realty Trust (HR)?
The last upgrade for Healthcare Realty Trust Inc happened on October 24, 2023 when BTIG raised their price target to $17. BTIG previously had a neutral for Healthcare Realty Trust Inc.
When was the last downgrade for Healthcare Realty Trust (HR)?
The last downgrade for Healthcare Realty Trust Inc happened on January 2, 2025 when Wedbush changed their price target from $18 to $16 for Healthcare Realty Trust Inc.
When is the next analyst rating going to be posted or updated for Healthcare Realty Trust (HR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthcare Realty Trust, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthcare Realty Trust was filed on March 10, 2025 so you should expect the next rating to be made available sometime around March 10, 2026.
Is the Analyst Rating Healthcare Realty Trust (HR) correct?
While ratings are subjective and will change, the latest Healthcare Realty Trust (HR) rating was a maintained with a price target of $17.00 to $16.00. The current price Healthcare Realty Trust (HR) is trading at is $16.88, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.